Nobel Laureate Offers Insight into Brain Function
The scientist whose research led to the discovery of the most common drug used to treat Parkinson's disease will speak Oct. 20 at UC.
Arvid Carlsson, MD, PhD, was awarded the Nobel Prize in Physiology or Medicine in 2000 for his discovery of the role of dopamine, a naturally occurring chemical "messenger" in the brain, in controlling movement. Dr. Carlsson, emeritus professor of pharmacology at the University of Gothenburg, Sweden, will present "The Dopamine System: Still an Important Target for Drug Discovery" at the annual Louis Lurie Memorial Lecture at 10:30 a.m., Wednesday, Oct. 20.
Louis Lurie, MD, was a pioneer in Cincinnati psychiatry. In 1920 he founded the Psychopathic Institute-which later became the Children's Psychiatric Center-and served as its director until 1948. A founding member of the American Academy of Child Psychiatry and president of the Cincinnati Society of Neurology and Psychiatry, Dr. Lurie died in 1979 at age 91.
For more information, call 513-558-4621.
Tags
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.